Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China
· Delayed Price · Currency is CNY 110.34
-0.98 (-0.88%)
Dec 5, 2025, 3:00 PM CST
SHA:688266 Market Cap
SHA:688266 has a market cap or net worth of 29.21 billion as of December 5, 2025. Its market cap has increased by 66.27% in one year.
Market Cap
29.21B
Enterprise Value
28.25B
Revenue
742.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
110.34
Market Cap Chart
Since January 23, 2020, SHA:688266's market cap has increased from 17.90B to 29.21B, an increase of 63.16%. That is a compound annual growth rate of 8.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 29.21B | 77.08% |
| Dec 31, 2024 | 16.49B | 17.70% |
| Dec 29, 2023 | 14.01B | 40.02% |
| Dec 30, 2022 | 10.01B | -29.08% |
| Dec 31, 2021 | 14.11B | -9.10% |
| Dec 31, 2020 | 15.53B | -13.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 404.98B |
| WuXi AppTec | 265.27B |
| Shenzhen Mindray Bio-Medical Electronics | 241.27B |
| Sichuan Biokin Pharmaceutical | 149.34B |
| Aier Eye Hospital Group | 106.90B |
| Shanghai United Imaging Healthcare | 105.68B |
| Zhangzhou Pientzehuang Pharmaceutical., | 103.46B |
| Yunnan Baiyao Group Co.,Ltd | 98.81B |